Simplify Exchange Traded Funds
Simplify Propel Opportunities ETF
$96.94M
Avg Monthly Net Assets
$97.15M
Total Assets
$205K
Total Liabilities
$96.94M
Net Assets
Simplify Propel Opportunities ETF is an Exchange-Traded Fund in Simplify Exchange Traded Funds
,
based in Nevada,
United States of America.
The fund has one share class
and monthly net assets of $96.94M.
On August 20th, 2024 it reported 26 holdings, the largest
being Plains GP Holdings LP (26.6%), Applied Therapeutics Inc (13.6%) and Madrigal Pharmaceuticals Inc (6.7%).
Data provided by Fincoded.
Share Classes
Name | Class/Contract ID | Exchange | Ticker | Monthly Returns (2 years) |
---|---|---|---|---|
Simplify Propel Opportunities ETF | C000238807 | ARCX | SURI |
Holdings
From latest NPORT-P, filed August 20th, 2024 for period ending June 28th, 2024.
Historic holdings data available from Fincoded.
Name | Profile | Category | Country | Value $USD | # Shares | % of Fund |
---|---|---|---|---|---|---|
Abeona Therapeutics Inc | Long | Equity-common | US | $2M | 409K | 1.79 |
Achieve Life Sciences Inc | Long | Equity-common | US | $1M | 218K | 1.06 |
Akero Therapeutics Inc | Long | Equity-common | US | $5M | 212K | 5.14 |
Applied Therapeutics Inc | Long | Equity-common | US | $13M | 3M | 13.57 |
Ardelyx Inc | Long | Equity-common | US | $4M | 598K | 4.57 |
Athira Pharma Inc | Long | Equity-common | US | $4M | 1M | 4.08 |
Avidity Biosciences Inc | Long | Equity-common | US | $5M | 125K | 5.27 |
CHINOOK THERAPEUTICS INC CVR | Long | Equity-common | US | $10K | 25K | 0.01 |
Cybin Inc | Long | Equity-common | CA | $136K | 500K | 0.14 |
Eiger BioPharmaceuticals Inc | Long | Equity-common | US | $1M | 90K | 1.17 |
FIDELITY INV MMTRSY 1 680 | Long | Equity-common | US | $317K | 317K | 0.33 |
Fulcrum Therapeutics Inc | Long | Equity-common | US | $3M | 465K | 2.97 |
Kayne Anderson Energy Infrastructure Fund | Long | Equity-common | US | $2M | 147K | 1.57 |
Kura Oncology Inc | Long | Equity-common | US | $2M | 80K | 1.70 |
Kymera Therapeutics Inc | Long | Equity-common | US | $911K | 31K | 0.94 |
MaaT Pharma SACA | Long | Equity-common | FR | $10K | 1K | 0.01 |
Madrigal Pharmaceuticals Inc | Long | Equity-common | US | $7M | 23K | 6.73 |
Phathom Pharmaceuticals Inc | Long | Equity-common | US | $5M | 522K | 5.55 |
Plains GP Holdings LP | Long | Equity-common | US | $26M | 1M | 26.64 |
Syndax Pharmaceuticals Inc | Long | Equity-common | US | $1M | 50K | 1.06 |
Telesat Canada / Telesat LLC (TELESAT CANADA/TELESAT L) | Long | Debt | CA | $2M | – | 1.98 |
Telesat Canada / Telesat LLC (TELESAT CANADA/TELESAT L) | Long | Debt | CA | $1M | – | 1.32 |
Telesat Corp | Long | Equity-common | CA | $3M | 366K | 3.43 |
Trevi Therapeutics Inc | Long | Equity-common | US | $596K | 200K | 0.61 |
TScan Therapeutics Inc | Long | Equity-common | US | $6M | 1M | 6.32 |
Verrica Pharmaceuticals Inc | Long | Equity-common | US | $2M | 280K | 2.11 |
Address
Simplify Exchange Traded Funds
10845 Griffith Peak Drive
2/F
Las Vegas
Nevada
89135
United States of America
Websites
Directors
Zung Nguyen
Paul Kim
Craig Enders
Christopher D Caltagirone
Transfer Agents
The Bank of New York Mellon
Pricing Services
Intercontinental Exchange, Inc.
Bloomberg Finance L.P.
Refinitiv
Custodians
The Bank of New York Mellon
Standard Chartered Bank, India Branch
Shareholder Servicing Agents
The Bank of New York Mellon
Admins
The Bank of New York Mellon
Brokers
Kotak Securities Limited